Inovio Pharmaceuticals Inc (INO)

06:49 AM

Inovio Pharmaceuticals: Hold Rating Due to Financial Losses and Uncertain Development Timeline - TipRanks

06:49 AM

06:08 AM

Inovio stock holds $12 target, JMP affirms Market Outperform - Investing.com Australia

06:08 AM

05:09 AM

Inovio stock holds $12 target, JMP affirms Market Outperform By Investing.com - Investing.com India

05:09 AM

03:15 AM

Inovio Pharmaceuticals Inc (INO) Q1 2025 Earnings Call Highlights: Strategic Cost Management ... - Yahoo Finance

03:15 AM

12:55 PM

Inovio Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat

12:55 PM

May 13, 2025

Inovio Pharmaceuticals (INO) Advances BLA Submission for INO-310 - GuruFocus

May 13, 2025

May 13, 2025

INOVIO Reports First Quarter 2025 Financial Results and Recent B - GuruFocus

May 13, 2025

May 13, 2025

Earnings call transcript: Inovio’s Q1 2025 sees narrowed losses, stock rises - Investing.com

May 13, 2025

May 13, 2025

Inovio Pharmaceuticals (INO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 13, 2025

May 13, 2025

Inovio: Q1 Earnings Snapshot - San Francisco Chronicle

May 13, 2025

May 13, 2025

INO Reports Strong Q1 Revenue, Progress on INO-3107 Submission | - GuruFocus

May 13, 2025

May 13, 2025

Inovio Pharmaceuticals Inc (INO) Q1 2025 Earnings: EPS of -$0.51 - GuruFocus

May 13, 2025

May 13, 2025

Inovio Pharmaceuticals Q1 Operating Expenses USD 25.1 Million - marketscreener.com

May 13, 2025

May 13, 2025

INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights - PR Newswire

May 13, 2025

May 13, 2025

Inovio Pharmaceuticals (NASDAQ:INO) Lowered to “Sell” Rating by StockNews.com - Defense World

May 13, 2025

May 11, 2025

Inovio Pharmaceuticals (INO) Expected to Announce Quarterly Earnings on Tuesday - Defense World

May 11, 2025

May 08, 2025

Inovio at The Citizens JMP Life Sciences Conference: DNA Platform Progress - Investing.com Australia

May 08, 2025

May 05, 2025

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Shares Sold by Renaissance Technologies LLC - Defense World

May 05, 2025

May 05, 2025

Inovio Pharmaceuticals (NASDAQ:INO) Cut to Sell at StockNews.com - Defense World

May 05, 2025

May 03, 2025

INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025 - Kilgore News Herald

May 03, 2025

May 02, 2025

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

May 02, 2025

May 02, 2025

INOVIO to Announce Q1 2025 Results and Host Live Webcast on May 13 - MyChesCo

May 02, 2025

May 01, 2025

Geode Capital Management LLC Boosts Stake in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Defense World

May 01, 2025

May 01, 2025

INOVIO to Present at Upcoming Scientific and Investor Conferences - The Bradford Era

May 01, 2025

Apr 30, 2025

INOVIO to Present at Upcoming Scientific and Investor Conferences | INO Stock News - GuruFocus

Apr 30, 2025

Apr 30, 2025

XTX Topco Ltd Acquires New Position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Defense World

Apr 30, 2025

Apr 30, 2025

INOVIO Reveals Breakthrough: DNA Therapy INO-3107 Cuts RRP Surgeries by 81%First Long-Term Data - Stock Titan

Apr 30, 2025

Apr 29, 2025

INOVIO Q1 2025 Earnings: DNA Medicine Leader to Reveal Latest Financial Performance May 13 - Stock Titan

Apr 29, 2025

Apr 27, 2025

Bank of Montreal Can Makes New $43,000 Investment in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Defense World

Apr 27, 2025

Apr 25, 2025

Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch

Apr 25, 2025

Apr 24, 2025

Inovio Pharmaceuticals Inc. stock rises Thursday, still underperforms market - MarketWatch

Apr 24, 2025

Apr 24, 2025

Human Papillomavirus Market Set for Breakthrough Expansion - openPR.com

Apr 24, 2025

Apr 23, 2025

Inovio Pharmaceuticals Inc. stock rises Wednesday, still underperforms market - MarketWatch

Apr 23, 2025

Apr 21, 2025

Bet on These 5 Top-Ranked Stocks With Rising P/E - Nasdaq

Apr 21, 2025

Apr 20, 2025

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Apr 20, 2025

Apr 19, 2025

Inovio Pharmaceuticals (NASDAQ:INO) Raised to “Hold” at StockNews.com - Defense World

Apr 19, 2025

Apr 17, 2025

Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial - ADVFN

Apr 17, 2025

Apr 17, 2025

Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Apr 17, 2025

Apr 16, 2025

Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Apr 16, 2025

Apr 11, 2025

Inovio Pharmaceuticals Inc. stock rises Friday, still underperforms market - MarketWatch

Apr 11, 2025

Apr 11, 2025

INOVIO to Highlight Breakthrough Immunotherapy Data at AACR Conference - MSN

Apr 11, 2025

Apr 11, 2025

INOVIO to Showcase Breakthrough Data on INO-3107 at Major Industry Conferences - MyChesCo

Apr 11, 2025

Apr 10, 2025

Inovio (INO) Upgraded to Buy: Here's What You Should Know - MSN

Apr 10, 2025

Apr 10, 2025

INOVIO Reports Inducement Grant Under Inducement Plan - MarketScreener

Apr 10, 2025

Apr 10, 2025

Next-generation Covid-19 vaccines currently being tested - Yahoo Finance

Apr 10, 2025

Apr 09, 2025

INOVIO to Present at Upcoming Scientific Conferences | INO Stock News - GuruFocus

Apr 09, 2025

Apr 09, 2025

INOVIO to Present at Upcoming Scientific Conferences - Longview News-Journal

Apr 09, 2025